Molina Healthcare slides as 2026 profit reset, downgrades keep pressure on MOH
Molina Healthcare shares fell about 3% as investors continued to price in sharply lower 2026 earnings expectations after the company’s February guidance reset and Q4 loss tied to California Medicaid retroactive items. Recent analyst downgrades and target cuts have reinforced concerns about Medicaid margin durability and capital flexibility.
1. What’s moving the stock
Molina Healthcare (MOH) was down about 3.28% to $134.45 as the market continued to digest the company’s weaker 2026 earnings profile and the risk that state Medicaid actions can quickly hit profitability. The pressure follows Molina’s recent guidance reset and investor focus on Medicaid rate adequacy, medical cost trend, and the potential for additional retroactive adjustments.
2. The fundamental overhang: retroactive Medicaid items and higher medical costs
The latest selloff traces back to Molina’s Q4 2025 results and 2026 outlook, where the company reported an adjusted loss and highlighted retroactive items in California Medicaid alongside elevated medical cost ratios in Medicare and Marketplace. The California retro actions were described as a meaningful earnings headwind, raising investor sensitivity to state-level rate and settlement mechanisms and the concentration of exposure in large Medicaid markets.
3. Wall Street reaction keeps sentiment fragile
Analyst actions over recent weeks have skewed negative, including a notable downgrade to Equal Weight and multiple price-target cuts that emphasize reduced confidence in Molina’s ability to sustain Medicaid earnings and execute its 2026 plan. With the next earnings date approaching (Apr. 29, 2026, after market close), positioning remains cautious as investors wait for clearer evidence that medical cost trends and state reimbursement are aligning.